1
/
of
1
Elabscience
SKU:E-AB-F1051C-200Tests
FITC Anti-Human CD62L Antibody[DREG56]
FITC Anti-Human CD62L Antibody[DREG56]
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
The FITC Anti-Human CD62L Antibody [DREG56] is a highly specific and reliable tool for the detection and analysis of CD62L expression in human samples. This antibody is conjugated with FITC, a fluorochrome that emits a bright green fluorescence upon excitation, allowing for easy visualization and quantification of CD62L-positive cells.
CD62L, also known as L-selectin, is a cell adhesion molecule that plays a crucial role in the migration and homing of lymphocytes to secondary lymphoid organs. It is primarily expressed on the surface of naive and central memory T cells, as well as on a subset of B cells and neutrophils. The expression of CD62L is tightly regulated and can be modulated by various factors, making it an important marker for immune cell activation and differentiation.
The FITC Anti-Human CD62L Antibody [DREG56] has been extensively validated for flow cytometry applications, ensuring accurate and reproducible results. It exhibits high specificity, minimal background staining, and excellent signal-to-noise ratio, enabling precise identification and characterization of CD62L-positive cells within complex cell populations.
This antibody is supplied in a convenient format, ready-to-use for flow cytometry experiments. It is recommended for use in both research and clinical settings, facilitating investigations into immune cell trafficking, immune responses, and disease pathogenesis. With its exceptional performance and reliability, the FITC Anti-Human CD62L Antibody [DREG56] is an indispensable tool for immunologists and researchers studying lymphocyte migration and immune cell dynamics.
CD62L, also known as L-selectin, is a cell adhesion molecule that plays a crucial role in the migration and homing of lymphocytes to secondary lymphoid organs. It is primarily expressed on the surface of naive and central memory T cells, as well as on a subset of B cells and neutrophils. The expression of CD62L is tightly regulated and can be modulated by various factors, making it an important marker for immune cell activation and differentiation.
The FITC Anti-Human CD62L Antibody [DREG56] has been extensively validated for flow cytometry applications, ensuring accurate and reproducible results. It exhibits high specificity, minimal background staining, and excellent signal-to-noise ratio, enabling precise identification and characterization of CD62L-positive cells within complex cell populations.
This antibody is supplied in a convenient format, ready-to-use for flow cytometry experiments. It is recommended for use in both research and clinical settings, facilitating investigations into immune cell trafficking, immune responses, and disease pathogenesis. With its exceptional performance and reliability, the FITC Anti-Human CD62L Antibody [DREG56] is an indispensable tool for immunologists and researchers studying lymphocyte migration and immune cell dynamics.
Share
![FITC Anti-Human CD62L Antibody[DREG56]](http://danabiosci.com/cdn/shop/products/elisa-1_5e265e2e-ffd6-4a5d-9439-ddcc7486c4fd.jpg?v=1706730189&width=1445)